EODData

MEMBERSHIP REGISTER LOG IN

FRA, IDD: Innate Pharma S.A

15 Jul 2026
LAST:

1.560

CHANGE:
 0.01		OPEN:
1.560		HIGH:
1.560		ASK:
0.000		VOLUME:
0
CHG(%):
0.51		PREV:
1.568		LOW:
1.560		BID:
0.000		 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
15 Jul 261.5601.5601.5601.5600
14 Jul 261.5681.5681.5681.5680
13 Jul 261.5501.5501.5501.5500
10 Jul 261.5601.5601.5601.5600
09 Jul 261.5821.5821.5821.5820
08 Jul 261.6401.6401.6401.6400
07 Jul 261.6741.6741.6741.6740
06 Jul 261.6341.6341.6341.6340
03 Jul 261.5801.5801.5801.5800
02 Jul 261.5941.5941.5941.5946.3K

PROFILE

Name:Innate Pharma S.A
About:Innate Pharma S.A. operates as a biotechnology company that develops immunotherapies for cancer patients in France and internationally. The company's products include Lacutamab (IPH4102), an anti-KIR3DL2 antibody, which is in Phase II clinical trials for the treatment of cutaneous T-cell and peripheral T-cell lymphoma, as well as in Phase II clinical trials to treat refractory sézary syndrome; Monalizumab, an immune checkpoint inhibitor that is in Phase III clinical trial to treat advanced solid tumors comprising colorectal and lung cancer, as well as head and neck cancer; IPH5201, a blocking antibody that is in Phase II clinical trials targeting the CD39 immunosuppressive pathway; IPH5301, an anti-CD73 antibody targeting the immunosuppressive adenosine pathway to promote antitumor immunity; IPH6401, an BCMA-targeting NK cell engager; and IPH6101, a NKp46-based NK cell engager that targets CD123 proprietary multi-specific antibody format; and IPH62, an B7-H3-targeting NK cell engager. Its products in preclinical trials are IPH43, an anti-MICA/B ADC and IPH45, an antibody drug conjugates (ADC); and IPH67, an undisclosed, multi-specific ANKET. The company has licensing and collaboration agreements with AstraZeneca, Novo Nordisk A/S, Sanofi, and Orega Biotech; and co-development and license agreement with MedImmune Limited. Innate Pharma S.A. was incorporated in 1999 and is based in Marseille, France.
Sector:Healthcare
Industry:Biotechnology
Address:117, Avenue de Luminy, Marseille, France, 13009
Website:https://www.innate-pharma.com
ISIN:FR0010331421

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

  Download

FUNDAMENTALS

Trailing P/E:-2.52 
Price to Sales:16.27 
Price to Book:27.43 
Operating Margin:-6.90 
Return on Assets:-0.39 
Return on Equity:2.27 
Revenue:9.01M 
Shares:92.17M 
Market Cap:143.78M 

TECHNICAL INDICATORS

MA5:1.560.3%
MA10:1.592.2%
MA20:1.591.9%
MA50:1.550.4%
MA100:1.4111.0%
MA200:1.513.4%
STO9:8.06 
STO14:8.06 
RSI14:37.50 
WPR14:-91.94 
MTM14:-0.01
ROC14:0.00 
ATR:0.03 
Week High:1.645.1%
Week Low:1.550.6%
Month High:1.677.3%
Month Low:1.543.4%
Year High:2.1034.3%
Year Low:1.0450.0%
Volatility:19.24